FDA Accepts Application for Opdivo Plus Yervoy as First-Line Treatment for Unresectable Hepatocellular Carcinoma

Acceptance based on Phase 3 CheckMate -9DW trial results demonstrating improved survival with Opdivo (nivolumab) plus Yervoy(ipilimumab) compared to in...

August 22, 2024 | Thursday | News
Roche Strengthens Global Response to Mpox Outbreak with Advanced PCR Testing Solutions

Roche is committed to supporting all those working to overcome the mpox outbreak by providing access to high-quality Polymerase Chain Reaction (PCR) te...

August 21, 2024 | Wednesday | News
GE HealthCare Partners with UC San Diego to Enhance MRI Techniques for Women's Pelvic Health

Project aims to increase access of advanced imaging techniques for clinicians to help drive improved diagnosis and management of female pelvic di...

August 20, 2024 | Tuesday | News
QIAGEN Singapore Partners with Parkway Group to Enhance Patient Care through Advanced Syndromic Testing

Collaboration to improve patient care and epidemiological monitoring in Parkway Group's  private hospitals  QIAstat-Dx syndromic testing to pr...

August 20, 2024 | Tuesday | News
Bavarian Nordic Ramps Up Mpox Vaccine Production Amid Africa CDC's Public Health Emergency Declaration

Bavarian Nordic A/S (OMX: BAVA) provides an update on plans for securing supply of vaccines to tackle the current mpox outbreak that the Africa Centers f...

August 19, 2024 | Monday | News
Fapon Biotech Strengthens Global Response to Monkeypox with Innovative Antigen Diagnostics

  Fapon Biotech is a global leader in the In-vitro Diagnostics (IVD) industry, with a steadfast commitment to advancing global health by providing in...

August 19, 2024 | Monday | News
Lykos Therapeutics Restructures to Focus on Resubmission of NDA for PTSD Treatment Midomafetamine

Lykos Therapeutics ("Lykos"), a company dedicated to transforming mental healthcare, today announced a reorganization to best support the company as...

August 16, 2024 | Friday | News
Gilead Sciences Announces FDA Accelerated Approval for Livdelzi® in Treating Primary Biliary Cholangitis

Gilead Sciences, Inc.  announced that the U.S. Food and Drug Administration (FDA) has granted accelerated approval for Livdelzi® (seladelpar) fo...

August 15, 2024 | Thursday | News
Mangoceuticals Secures 20-Year Patent in India for Innovative Preventive Health Technology

Mangoceuticals, Inc. \ a company focused on developing, marketing, and selling a variety of men’s health and wellness products in the area of ...

August 14, 2024 | Wednesday | News
Stereotaxis Announces CE Mark Approval and FDA Submission for Revolutionary GenesisX Robotic System

Stereotaxis, a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced it obtained CE mark in Eu...

August 13, 2024 | Tuesday | News
FDA Approves First Non-Injection Epinephrine Nasal Spray, Neffy, for Life-Threatening Allergic Reactions

U.S. Food and Drug Administration approved neffy (epinephrine nasal spray) for the emergency treatment of allergic reactions (Type I), including those th...

August 12, 2024 | Monday | News
C2N Diagnostics and Unilabs Partner to Expand Precivity™ Blood Tests for Alzheimer’s Diagnosis to Over 75 Countries

Partnership Expands Reach of C2N’s Precivity™ Blood Tests in Over 75 Countries to Transform Alzheimer’s Disease Early Diagnosis...

August 08, 2024 | Thursday | News
Kyowa Kirin International Partners with NewBridge Pharmaceuticals to Distribute Rare Disease Treatments in Middle East and North Africa

Agreement will see NewBridge Pharmaceuticals act as a multi-country distributor in four countries across the Middle East and North Africa (MENA) ...

August 07, 2024 | Wednesday | News
Thermo Fisher Scientific's SeCore™ CDx HLA A Sequencing System Receives FDA Clearance as Companion Diagnostic for Adaptimmune’s TECELRA® TCR Therapy

Thermo Fisher Scientific Inc., the world leader in serving science,  announced that its SeCore™ CDx HLA A Sequencing System has been granted 5...

August 07, 2024 | Wednesday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2024 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close